A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- ‘CA-125 is a valuable tool’ for women with ovarian cancer symptomson December 11, 2019 at 6:50 am
“Currently, the majority of women are not diagnosed until the disease is advanced,” Garth Funston, BSc, MB, clinical research fellow at the University of Cambridge, told Healio Primary Care. “Less ...
- IPRO Creates Kidney Disease Management Toolson December 10, 2019 at 3:01 pm
IPRO's CKD Screening App guides physicians in identifying patient CKD risk, selecting appropriate lab tests for diagnosis and making disease staging determination ... View original ...
- Biotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & Diagnosison December 10, 2019 at 2:00 pm
we are expanding our offerings from environmental testing and research-use patient tests to patient diagnostics to provide hospitals with better tools to diagnose and control infectious disease ...
- This D.C. biotech is raising millions — and getting its blood test for heart disease closer to realityon December 10, 2019 at 12:15 pm
Tisha Jepson has an ambitious to-do list: Advance clinical studies of her blood test for heart disease, publish research to get payers to cover it, raise millions to build a lab, earn regulatory ...
- Co-Diagnostics, Inc. Launches Vector Control Mosquito Test for EEE Viruson December 10, 2019 at 4:25 am
EEE is a mosquito-borne disease that kills roughly one-third of those infected and typically leaves ... “Since the launch of our NAM-w test earlier this year, developing a diagnostic tool to identify ...
- South Dakota's new diagnostic lab now open for businesson December 9, 2019 at 10:37 am
The newest tool for fighting animal diseases in South Dakota is now open for business. Over the weekend, the transfer of lab equipment from the state's existing Animal Disease Research & Diagnostic ...
- Point Of Care (POC) Diagnostics Market Share, Size 2017-2025 | Top Leading Countries, Companies,on December 9, 2019 at 5:28 am
diagnostics, are medical devices or tools that helps to diagnose the disease in patient's community, usually outside of clinical labs. The point of care allows earlier diagnostics of disease and to ...
- Infectious Disease Diagnostics Market 2019 Size, Share, Trends, Analysis and Growth Forecast to 2025|MRE Reporton December 5, 2019 at 6:46 pm
Infectious disease medicine is method of distinctive the presence of foreign antigen/organism with the assistance of assorted diagnostic tools. Communicable disease conditions area unit extremely ...
- First investigational drug therapy for liver disease NASH awaiting FDA approvalon December 5, 2019 at 3:34 pm
Given the silent nature of the disease, many patients progress to cirrhosis without being diagnosed. While developing an approved therapy is critical, it also will be important to develop simple ...
- 6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Booston December 4, 2019 at 8:16 pm
Others are working on an intimately related problem: early detection of the disease and related dementias. On Wednesday the New York-based Alzheimer’s Drug Discovery Foundation (ADDF) named six ...
via Bing News